Seeking Alpha

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology

—New Peer-Reviewed Publication Highlights Phase 2 SPRING Trial Data Supporting the Disease Modifying Potential of Nebokitug in PSC and Supports Advancement to a Phase 3 Registration Trial— TEL AVIV, ...
Sports Illustrated

Kansas State Starts Second Phase Of Spring After Massive Gains In Weight Room

Kansas State spent more time in the first phase of their offseason workouts. "Phase One" officially ended on Wednesday. Kansas State head coach Chris Klieman said that many different people were ...
Nasdaq

Chemomab Therapeutics Reports Promising Phase 2 SPRING Trial Data for Nebokitug, Showing Significant Improvements in Biomarkers for Primary Sclerosing Cholangitis and Other ...

Chemomab Therapeutics announced new findings from the Phase 2 SPRING trial that highlight the potential of their treatment, nebokitug, for primary sclerosing cholangitis (PSC) and other ...